years, predominantly as a result of improved respiratory care. 2 3 Death, however, continues Background -The treatment for endstage cystic fibrosis is, where appropriate, to be due, in most cases, to respiratory failure associated with cor pulmonale and pulmonary double-lung, heart-lung or, occasionally, heart-lung-liver transplantation. Op-hypertension.
age range of 13-45 years (10-90% with age (p<0.05) associated with survival when ana- * These variables were recorded only at entry to the study. lysed by either test were then entered in a stepwise manner into both forward and backward stepping, time dependent, multivariate Cox regression analysis to select the subset of zyme supplements; malabsorption defined as frequent, loose, pale or offensive stools that variables which best predicted survival.
11
Multivariate Cox regression analysis requires were difficult to flush away) and subsequent annual outpatient assessments. Routine haem-that all patients be represented by a complete data set at the time of entry to the study so atology, serum biochemistry, and measurements of pulmonary function, nutritional only 373 patients were included in the final analysis. The significant variables were comand hepatic status were performed at these visits during periods of stability. Patients in bined into a predictive index (PI) and used to produce estimates of survival. whom data collection was incomplete were not included in the analysis. These routine data Multivariate Cox regression analysis produces a model of two parts. The first part is were collected prospectively on a computerised data base. Pulmonary function and weight were related to the current medical status and is therefore a function of PI, and the second is a expressed as a percentage of the expected value.
9 10 multiplying hazard function (the risk of dying at any particular point in time) which is conThe year of entry to the study, considered to be the date of first full assessment at the stant for all patients at that time point.
11 If, as we later show, this underlying hazard function Brompton Hospital, was included in all analyses to allow for the possible effect of changes is constant over time, such that the risk of dying at or before a given time point increases linearly in referral patterns and the development of improved treatment regimes. In addition, as over time, then the probability of survival at any time point can be directly estimated from the diagnosis of cystic fibrosis had been made some time before the initial assessment for most the PI. of the study population, the time from diagnosis to entry was calculated and entered into the analysis.
    Internally (within cohort A) Sixteen patients were lost to follow up but were included in the analysis until the date they The model was validated for prediction of one year survival using split sample testing. 11 The were last known to be alive. Three had returned to their homes abroad, 11 were transferred data base of 373 patients was randomly divided into two parts. The model was regenerated to other hospitals, and no information was available for the other two. Seven patients using three quarters of the data base and applied to the remaining one quarter. A predictive underwent transplantation during follow up and were therefore included until the date of score was generated, at all time points, for each of the remaining patients using the model and, transplantation. At this point they were excluded from further analysis and, for the pur-in combination with the underlying hazard function, used to calculate the probability of a pose of the study, were regarded as having died during the period of follow up. particular patient dying within one year. The observed and expected numbers of deaths were compared using the 2 test. Cohort B A second cohort of patients, recruited between October 1988 and September 1993, was used Externally (using cohort B)
The predictive index (PI) was generated for for validation purposes (cohort B). This data set included 100 patients (50 male) with an each patient and the probability of dying within group.bmj.com on June 22, 2017 -Published by http://thorax.bmj.com/ Downloaded from divided into five groups, the probabilities of death were calculated for each group to give the expected number of deaths for that group, and a comparison with the actual number of deaths was made using the 2 test.
Results
The patient characteristics are shown in table 1. Three hundred and seventy three patients (169 male) of median age 20 years (range 11-63) were included in the final analysis, of which 188 (50.4%) died. The factors significant by either log rank analysis or univariate time dependent Cox re- Figure 2 Graph relating predictive index to survival gression analysis are shown in table 1. Age, probability. sex, year of entry into the study, and time from diagnosis to entry into the study were not deviating only as the numbers of patients besignificant predictors of survival after the final came small at seven years ( fig 1) . Thus, graphs analysis.
relating the predictive index to the probability Time dependent multivariate Cox regression of survival over set periods of time can be analysis revealed percentage predicted FEV 1 , generated ( fig 2) and allow an estimate of the percentage predicted FVC, height (m), white probability of survival to be made for specific blood cell count (WBC, ×10 9 /l), hepatomegaly periods of time. For example, for a patient of (palpable liver, confirmed by increased liver height 1.54 m who presents with hepatospan), serum concentrations of albumin (g/l) megaly=1 (present), FVC=50% predicted, and alkaline phosphatase (ALP, IU/l) as factors FEV 1 =35% predicted, and WBC=20×10 9 /l significantly associated with survival. Serum the predictive index is obtained by multiplying concentrations of albumin and ALP were exeach variable by its coefficient: cluded from the final model, the former because PI=(−3.410×1.54)+(0.990×1)−(0.038× its coefficient within the predictive model was 50)−(0.059×35)+(0.090×20)=−6.4 only 0.0001 and the latter because, for inFrom fig 2 it can be seen that this patient dividual patients, there was concern that bone has a 75% estimated chance of surviving six related ALP might introduce a considerable months, but only a 56% chance of surviving inaccuracy.
one year. The remaining significant variables (table 2) were combined to produce the final model:
Internal (cohort A) ×WBC) where the presence of hepato-
The validation was performed twice. The data megaly =1; absence=0.
base was randomly split so that the first validation of the model used the "first" three quarters of the data, and the second used the     "last" three quarters of the data base. In the The underlying hazard for this cohort of first case the observed number of deaths was patients was constant over time (r=0.996), 65 and the expected number 60 ( 2 =0.41; p>0.4 (NS)), and in the second there were to use variables that were universally available and easily measured. The failure of both the age and sex of the Discussion This study has enabled the construction of a patients to reach statistical significance within the model is at variance with some, 2 8 18 19 but model to predict short and medium term survival in patients with cystic fibrosis which has not all, 20 21 previous reports. It has been suggested that the influence of both these factors been validated within the study population (cohort A) and in a cohort recruited after October on survival is related to the nutritional status of the patient. 13 The inclusion of patient height, 1988 (cohort B). We believe this is the first report of a time dependent predictive model in which may reflect nutritional status (see below), in this model may have resulted in the exclusion this disease.
Its application to other cystic fibrosis popu-of age and sex from the prognostic index. However, this interrelationship between age, sex, lations remains to be assessed, but its confirmation by external validation, albeit in a and nutrition has not been universally reported with the most recent predictive model reporting cohort of patients referred to the same centre (but one which probably reflects the changing an increased risk of death in young females with cystic fibrosis even when allowance is referral patterns consequent upon the more widespread availability of specialised cystic fib-made for weight differences. While pulmonary function has not always rosis centres in the UK), suggests wide applicability. This presumption is supported by been found to correlate with survival, 20 other reports have documented the importance of reported similarities in median survival for patients with cystic fibrosis in the UK, 12 deteriorating FEV 1 and of carbon dioxide retention.
8 22 23 Within this model both per-USA, 13 Canada, 13 and Denmark.
14 The results of the external validation indicate centage predicted FEV 1 and FVC were negatively correlated with survival. The inclusion the accuracy of the model in predicting the prognosis of patients with cystic fibrosis who of two parameters which reflect pulmonary disease suggests that each provides inare particularly unwell. This group is the one most likely to be considered for transplantation, dependent prognostic information, although the mechanism for their independent effect suggesting that this model will allow accurate identification of patients in need of trans-upon survival is unclear.
Other parameters reflecting pulmonary funcplantation (table 3) .
The characteristics of the cohort within this tion, including oxygen saturation and arterial blood gas measurements, were not included study were determined by hospital referral patterns and resulted in the analysis being of a in the analysis as these were not routinely performed before the mid 1970s. However, the predominantly adult population. This limits its applicability to the adult cystic fibrosis popu-importance of the arterial blood gas tensions in prognostic evaluation is well recognised 8 and lation but does not, however, diminish its value.
While there have been marked improvements it is hoped to be able to include them in future analyses. in the management of patients with cystic fibrosis over the considerable time period of reNutritional status has also been documented as an important predictor of prognosis 13 20 cruitment to this study, and also changes in the pattern of patient referral to the Brompton although there are no studies to show that nutritional intervention leads to improvement Hospital resulting recently in a more ill patient population (predominantly those with com-in long term survival. 24 In this analysis taller patients survive longer. The precise relationship plications that have proved difficult to manage or those in need of transplant assessment), the of height to survival remains unclear, but failure of statural growth probably reflects a degree of failure of the year of entry into the study to reach statistical significance in the multivariate malnutrition 25 and may also be a long term marker of disease severity. analysis suggests that any influence of these changes in patient population and treatment
The prognostic model also includes two factors that have not previously been reported as regimes on survival is accounted for by the variables included in the model. These changes predictors of outcome. The negative correlation of a high WBC (measured on blood samples do not therefore reduce the value of the prognostic index. Furthermore, the prognosis of obtained during periods of stability) with survival may reflect chronic ongoing sepsis, prepatients recruited more recently, who are likely to reflect these changes in management and sumably of pulmonary origin, and the observation that WBC and pulmonary function referral practice, appears to be well modelled by the predictive index as demonstrated by the are independent prediction variables suggests that mechanisms other than pulmonary disease results of the external validation.
Comparison of the results of this analysis alone may be involved. It may be speculated that an increase in inflammatory mediators with previous studies is hampered by the fact that most previous reports of prognosis in cystic secondary to sepsis, such as tumour necrosis factor , may have a systemic adverse effect.
26
fibrosis have assessed variables that affect the long term outcome and are not directly comEstablished chronic liver disease, as manifest by hepatomegaly, also proved to be an imparable with this analysis. In addition, some measures which have been shown to be cor-portant negative correlate with survival. Con- 
